Freedom of Information request on the Vaccines Benefits Risk Working Group meetings since August 2020 and specifically the topic of 'side effects' of the Covid vaccines - has there been any mention of 'lymphocytic activity' post vaccine? (FOI 22/389)
Published 31 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-31-january-2022/freedom-of-information-request-on-the-vaccines-benefits-risk-working-group-meetings-since-august-2020-and-specifically-the-topic-of-side-effects-of
FOI 22/389
31st January 2022
Dear
Thank you for your email of 18 December 2021, where you requested the following information under the Freedom of Information Act:
‘With reference to the Vaccines Benefits Risk Working Group meetings since August 2020 and specifically the topic of ‘side effects’ of the Covid vaccines - has there been any mention of ‘lymphocytes’ or ‘lymphocytic activity’ post vaccine or post mortem?’
Apologies for the delay in responding to you. I can confirm that the MHRA does not hold the specific information you request. However, please advise if there is a particular safety topic in which you are interested.
If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.
The MHRA information supplied in response to your request is subject to Crown copyright. The FOIA only entitles you to access to MHRA information.
For information on the reproduction or re-use of MHRA information, please visit https://www.gov.uk/government/publications/reproduce-or-re-use-mhra-information/reproduce-or-re-use-mhra-information
If you have a query about this email, please contact us. If you are unhappy with our decision, you may ask for it to be reviewed. That review will be undertaken by a senior member of the Agency who has not previously been involved in your request. If you wish to pursue that option please write to the Communications Directorate, Medicines and Healthcare products Regulatory Agency, (via this email address). After that, if you remain dissatisfied, you may ask the Information Commissioner at:
The Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
Yours sincerely
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000